These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16133634)

  • 1. [Etanercept. An effective TNF alpha-antagonist in the treatment of psoriatic arthritis and chronic plaque psoriasis].
    Wozel G
    Hautarzt; 2005 Sep; 56(9):819-30. PubMed ID: 16133634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
    Goldsmith DR; Wagstaff AJ
    BioDrugs; 2005; 19(6):401-3. PubMed ID: 16392892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept.
    Ducharme E; Weinberg JM
    Expert Opin Biol Ther; 2008 Apr; 8(4):491-502. PubMed ID: 18352852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE; Clarke S
    J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infliximab. Role in the treatment of psoriasis].
    Mössner R; Reich K
    Hautarzt; 2005 Sep; 56(9):831-2, 834-8. PubMed ID: 16133635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
    Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept for the treatment of psoriasis and psoriatic arthritis.
    Gottlieb AB
    Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
    Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
    BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
    González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
    J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of etanercept in the treatment of psoriasis and psoriatic arthritis.
    Fuchs BS; Hadi S
    Rev Recent Clin Trials; 2006 Sep; 1(3):259-63. PubMed ID: 18473978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriatic arthritis: the role of TNF inhibition and the effect of its inhibition with etanercept.
    Mease P
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S116-21. PubMed ID: 12463460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 15. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist.
    Wong VK; Lebwohl MG
    Expert Opin Biol Ther; 2005 Nov; 5(11):1505-13. PubMed ID: 16255653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of etanercept in the dermatology setting. A review.
    Lebwohl MG
    Am J Clin Dermatol; 2005; 6(1):49-59. PubMed ID: 15675890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence.
    Strohal R; Chimenti S; Vena GA; Girolomoni G
    J Dermatolog Treat; 2013 Jun; 24(3):199-208. PubMed ID: 22812568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.